Torthaí cuardaigh - Christophe Georger
- 1 - 2 toradh as 2 á dtaispeáint
-
1
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C de réir Serge Herson, Fayçal Hentati, A. Rigolet, Anthony Béhin, Norma B. Romero, France Leturcq, Pascal Laforêt, Thierry Maisonobe, Rim Amouri, Hafedh Haddad, Muriel Audit, Marie Montus, Carole Masurier, Bernard Gjata, Christophe Georger, Mustapha Cheraï, Pierre G. Carlier, Jean‐Yves Hogrel, Ariane Herson, Yves Allenbach, François M. Lemoine, David Klatzmann, H. Lee Sweeney, Richard C. Mulligan, B. Eymard, Didier Caizergues, Thomas Voït, Olivier Benvéniste
Foilsithe / Cruthaithe 2011Artigo -
2
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy de réir Caroline Le Guiner, Laurent Servais, Marie Montus, Thibaut Larcher, B. Fraysse, Sophie Moullec, Marine Allais, Virginie François, Maéva Dutilleul, Alberto Malerba, Taeyoung Koo, Jean‐Laurent Thibaut, Béatrice Matot, Marie‐Françoise Devaux, Johanne Le Duff, Jack‐Yves Deschamps, Inès Barthélémy, Stéphane Blot, Isabelle Testault, Karim Wahbi, Stéphane Éderhy, Samia Martin, P. Véron, Christophe Georger, Takis Athanasopoulos, Carole Masurier, Federico Mingozzi, Pierre G. Carlier, Bernard Gjata, Jean‐Yves Hogrel, Oumeya Adjali, Fulvio Mavilio, Thomas Voit, Philippe Moullier, George Dickson
Foilsithe / Cruthaithe 2017Artigo